PK-PD

Advertisement

cGxPJobs Banner

CervoMed Advances Neflamapimod With New Tablet and FDA Dose Flexibility

BOSTON — September 28, 2026 CervoMed Inc. announced pharmacokinetic, regulatory and manufacturing advances for neflamapimod, including a new 50...

By cGxPwire Editor
September 29, 2026

Read More

Advertisement

cGxPJobs

Directory